SEC suggests a biannual reporting choice to take the place of quarterly submissions
Proposed Shift in Reporting Requirements for U.S. Companies In a notable change, U.S. financial regulators are suggesting that publicly traded companies transition from quarterly to semi-annual reporting. The Securities and Exchange Commission (SEC) made this announcement on Tuesday, detailing amendments that allow Wall Street firms to opt for voluntary semi-annual reporting. SEC officials clarified that […]
Gilead’s new biannual HIV prevention shot receives FDA clearance
The FDA Approves AI Tools for Breast Cancer Risk Assessment The U.S. Food and Drug Administration (FDA) has given the green light to two new shots, happening only once a year, aimed at preventing HIV, as announced by Gilead Sciences on Wednesday. The injectable medication, known as Lenacapavir and marketed under the name Yeztugo, significantly […]